Collaborating in the Care of Spinal Muscular Atrophy: A Multidisciplinary Approach to Timely Screening, Diagnosis, and Management

Article Type
Changed
Fri, 11/01/2019 - 11:20

How prepared are you to recognize and meet the needs of patients with spinal muscular atrophy?

Learn more about spinal muscular atrophy in this supplement to Neurology Reviews.

Click here to read. 

Supplement Faculty

Claudia A. Chiriboga, MD, MPH, FAAN
(Program Chair)
Professor of Neurology and Pediatrics at CUIMC
Division of Pediatric Neurology
Columbia University Irving Medical Center
New York, NY

 

Diana P. Castro, MD
Assistant Professor
Pediatrics and Neurology
Neurotherapeutics
UT Southwestern Medical Center
Neurologist
Children’s Health
Dallas, TX

 

Mary Schroth, MD
Chief Medical Offi cer
Cure SMA
Elk Grove Village, IL

 

Charlotte J. Sumner, MD
Professor of Neurology and Neuroscience
Johns Hopkins University School of Medicine
Baltimore, MD

 

Kathryn J. Swoboda, MD
Katherine B. Sims, MD, Endowed Chair
in Neurogenetics
Director, Neurogenetics Program
Mass General Hospital for Children
Boston, MA
Sponsor
This supplement is sponsored by Genentech, a member of the Roche Group.
Publications
Sections
Sponsor
This supplement is sponsored by Genentech, a member of the Roche Group.
Sponsor
This supplement is sponsored by Genentech, a member of the Roche Group.

How prepared are you to recognize and meet the needs of patients with spinal muscular atrophy?

Learn more about spinal muscular atrophy in this supplement to Neurology Reviews.

Click here to read. 

Supplement Faculty

Claudia A. Chiriboga, MD, MPH, FAAN
(Program Chair)
Professor of Neurology and Pediatrics at CUIMC
Division of Pediatric Neurology
Columbia University Irving Medical Center
New York, NY

 

Diana P. Castro, MD
Assistant Professor
Pediatrics and Neurology
Neurotherapeutics
UT Southwestern Medical Center
Neurologist
Children’s Health
Dallas, TX

 

Mary Schroth, MD
Chief Medical Offi cer
Cure SMA
Elk Grove Village, IL

 

Charlotte J. Sumner, MD
Professor of Neurology and Neuroscience
Johns Hopkins University School of Medicine
Baltimore, MD

 

Kathryn J. Swoboda, MD
Katherine B. Sims, MD, Endowed Chair
in Neurogenetics
Director, Neurogenetics Program
Mass General Hospital for Children
Boston, MA

How prepared are you to recognize and meet the needs of patients with spinal muscular atrophy?

Learn more about spinal muscular atrophy in this supplement to Neurology Reviews.

Click here to read. 

Supplement Faculty

Claudia A. Chiriboga, MD, MPH, FAAN
(Program Chair)
Professor of Neurology and Pediatrics at CUIMC
Division of Pediatric Neurology
Columbia University Irving Medical Center
New York, NY

 

Diana P. Castro, MD
Assistant Professor
Pediatrics and Neurology
Neurotherapeutics
UT Southwestern Medical Center
Neurologist
Children’s Health
Dallas, TX

 

Mary Schroth, MD
Chief Medical Offi cer
Cure SMA
Elk Grove Village, IL

 

Charlotte J. Sumner, MD
Professor of Neurology and Neuroscience
Johns Hopkins University School of Medicine
Baltimore, MD

 

Kathryn J. Swoboda, MD
Katherine B. Sims, MD, Endowed Chair
in Neurogenetics
Director, Neurogenetics Program
Mass General Hospital for Children
Boston, MA
Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 10/29/2019 - 12:30
Un-Gate On Date
Tue, 10/29/2019 - 12:30
Use ProPublica
CFC Schedule Remove Status
Tue, 10/29/2019 - 12:30
Hide sidebar & use full width
render the right sidebar.

Psoriasis & Psoriatic Arthritis: A Supplement

Article Type
Changed
Wed, 10/16/2019 - 11:44

This Psoriasis and Psoriatic Arthritis supplement to Dermatology News includes commentary from Alan Menter, MD, and Joel M. Gelfand, MD. Highlights include: Dosage cuts of biologics; AAD/NPF guidelines; the impact of comorbidities; weight loss and outcomes; and treatment of elderly patients.

 

Click here to read.

Publications
Sections

This Psoriasis and Psoriatic Arthritis supplement to Dermatology News includes commentary from Alan Menter, MD, and Joel M. Gelfand, MD. Highlights include: Dosage cuts of biologics; AAD/NPF guidelines; the impact of comorbidities; weight loss and outcomes; and treatment of elderly patients.

 

Click here to read.

This Psoriasis and Psoriatic Arthritis supplement to Dermatology News includes commentary from Alan Menter, MD, and Joel M. Gelfand, MD. Highlights include: Dosage cuts of biologics; AAD/NPF guidelines; the impact of comorbidities; weight loss and outcomes; and treatment of elderly patients.

 

Click here to read.

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Sponsored Supplement
Gate On Date
Mon, 10/14/2019 - 14:15
Un-Gate On Date
Mon, 10/14/2019 - 14:15
Use ProPublica
CFC Schedule Remove Status
Mon, 10/14/2019 - 14:15
Hide sidebar & use full width
render the right sidebar.

Federal Health Care Cancer Data Trends 2019

Article Type
Changed
Tue, 01/07/2020 - 13:56
Publications
Sections
Publications
Publications
Article Type
Sections
Citation Override
Fed Pract. 2019 September;36(suppl 5)
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 11/27/2018 - 14:15
Un-Gate On Date
Tue, 11/27/2018 - 14:15
Use ProPublica
CFC Schedule Remove Status
Tue, 11/27/2018 - 14:15
Hide sidebar & use full width
render the right sidebar.

Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Article Type
Changed
Fri, 12/04/2020 - 08:59
Display Headline
Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Read Now. 

With a recent renaissance in cancer diagnostics and treatment, there is hope for many fighting the disease. In this article, Dr. M. Patricia Rivera discusses screening and diagnostic procedures as well as the treatment options that are available for patients with unresectable stage III non-small cell lung cancer.

This article is sponsored by AstraZeneca.

Read Now. 

 

US-33194                                                                                      Last Updated 9/19        

Sponsor
This article is sponsored by AstraZeneca.
Sponsor Teaser Title Override
Sponsored Article.
Publications
Topics
Sections
Sponsor
This article is sponsored by AstraZeneca.
Sponsor
This article is sponsored by AstraZeneca.

Read Now. 

With a recent renaissance in cancer diagnostics and treatment, there is hope for many fighting the disease. In this article, Dr. M. Patricia Rivera discusses screening and diagnostic procedures as well as the treatment options that are available for patients with unresectable stage III non-small cell lung cancer.

This article is sponsored by AstraZeneca.

Read Now. 

 

US-33194                                                                                      Last Updated 9/19        

Read Now. 

With a recent renaissance in cancer diagnostics and treatment, there is hope for many fighting the disease. In this article, Dr. M. Patricia Rivera discusses screening and diagnostic procedures as well as the treatment options that are available for patients with unresectable stage III non-small cell lung cancer.

This article is sponsored by AstraZeneca.

Read Now. 

 

US-33194                                                                                      Last Updated 9/19        

Publications
Publications
Topics
Article Type
Display Headline
Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Display Headline
Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Sponsored Article
Gate On Date
Thu, 09/12/2019 - 12:00
Un-Gate On Date
Thu, 09/12/2019 - 12:00
Use ProPublica
CFC Schedule Remove Status
Thu, 09/12/2019 - 12:00
Hide sidebar & use full width
render the right sidebar.
Sponsor Teaser Title Override
Sponsored Article.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article

Hot Topics in Primary Care 2019

Article Type
Changed
Thu, 11/07/2019 - 15:27
Display Headline
Hot Topics in Primary Care 2019
J Fam Pract. 2019 October;68(8)


Click here to read Hot Topics in Primary Care.

This supplement includes 4 CME credits (scroll down for more information). 

Topics include: 

  • Chronic Kidney Disease in Type 2 Diabetes
  • Heart Failure in Type 2 Diabetes
  • Diabetes Management
  • Naproxen vs Opioids
  • Statin Selection
  • Insomnia in Alzheimer's Disease
  • Cluster Headache
  • Irritable Bowel Syndrome

This supplement offers the opportunity to earn a total of 4 CME credits. 

Credit is awarded for scucesful completion of the online evaluations at the links below. These links may also be found within the supplement on the first page of each article. 

Sponsor
This supplement was sponsored by Primary Care Education Consortium and Primary …
Issue
The Journal of Family Practice - 68(8)
Publications
Sections
Sponsor
This supplement was sponsored by Primary Care Education Consortium and Primary …
Sponsor
This supplement was sponsored by Primary Care Education Consortium and Primary …
J Fam Pract. 2019 October;68(8)
J Fam Pract. 2019 October;68(8)


Click here to read Hot Topics in Primary Care.

This supplement includes 4 CME credits (scroll down for more information). 

Topics include: 

  • Chronic Kidney Disease in Type 2 Diabetes
  • Heart Failure in Type 2 Diabetes
  • Diabetes Management
  • Naproxen vs Opioids
  • Statin Selection
  • Insomnia in Alzheimer's Disease
  • Cluster Headache
  • Irritable Bowel Syndrome

This supplement offers the opportunity to earn a total of 4 CME credits. 

Credit is awarded for scucesful completion of the online evaluations at the links below. These links may also be found within the supplement on the first page of each article. 


Click here to read Hot Topics in Primary Care.

This supplement includes 4 CME credits (scroll down for more information). 

Topics include: 

  • Chronic Kidney Disease in Type 2 Diabetes
  • Heart Failure in Type 2 Diabetes
  • Diabetes Management
  • Naproxen vs Opioids
  • Statin Selection
  • Insomnia in Alzheimer's Disease
  • Cluster Headache
  • Irritable Bowel Syndrome

This supplement offers the opportunity to earn a total of 4 CME credits. 

Credit is awarded for scucesful completion of the online evaluations at the links below. These links may also be found within the supplement on the first page of each article. 

Issue
The Journal of Family Practice - 68(8)
Issue
The Journal of Family Practice - 68(8)
Publications
Publications
Article Type
Display Headline
Hot Topics in Primary Care 2019
Display Headline
Hot Topics in Primary Care 2019
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 10/01/2019 - 08:15
Un-Gate On Date
Tue, 10/01/2019 - 08:15
Use ProPublica
CFC Schedule Remove Status
Tue, 10/01/2019 - 08:15
Hide sidebar & use full width
render the right sidebar.

Treatment for Iron Deficiency Anemia Associated With Heavy Menstrual Bleeding

Article Type
Changed
Thu, 09/26/2019 - 11:14

Iron deficiency anemia (IDA) is a serious health problem that affects millions of women globally. Heavy menstrual bleeding (HMB) is one of the most common causes of IDA in women in North America.

In this supplement to OBG Management, the authors describe the signs, symptoms, and laboratory evaluation for HMB and IDA, including a comprehensive diagnostic and treatment algorithm for the practicing physician. The authors also discuss the characteristics of iron-repletion therapies currently available in the United States to help you make the best choice for your patient.

Click here to read the supplement

Sponsor
Sponsored by American Regent.
Publications
Topics
Sections
Sponsor
Sponsored by American Regent.
Sponsor
Sponsored by American Regent.

Iron deficiency anemia (IDA) is a serious health problem that affects millions of women globally. Heavy menstrual bleeding (HMB) is one of the most common causes of IDA in women in North America.

In this supplement to OBG Management, the authors describe the signs, symptoms, and laboratory evaluation for HMB and IDA, including a comprehensive diagnostic and treatment algorithm for the practicing physician. The authors also discuss the characteristics of iron-repletion therapies currently available in the United States to help you make the best choice for your patient.

Click here to read the supplement

Iron deficiency anemia (IDA) is a serious health problem that affects millions of women globally. Heavy menstrual bleeding (HMB) is one of the most common causes of IDA in women in North America.

In this supplement to OBG Management, the authors describe the signs, symptoms, and laboratory evaluation for HMB and IDA, including a comprehensive diagnostic and treatment algorithm for the practicing physician. The authors also discuss the characteristics of iron-repletion therapies currently available in the United States to help you make the best choice for your patient.

Click here to read the supplement

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 09/26/2019 - 11:00
Un-Gate On Date
Thu, 09/26/2019 - 11:00
Use ProPublica
CFC Schedule Remove Status
Thu, 09/26/2019 - 11:00
Hide sidebar & use full width
render the right sidebar.

Antibiotic Resistance: What the Dermatologist Needs to Know

Article Type
Changed
Mon, 09/23/2019 - 15:17

James Q. Del Rosso, DO, answers important questions on antibiotic resistance and what it means for the practicing dermatologist.

Questions include:

  • What is the potential magnitude of concern regarding antibiotic resistance? Is it clinically relevant to dermatologists in their day-to-day practice?

  • What can dermatologists do to slow the development of antibiotic resistance?

  • What is the mutant selection window?

  • How does the mutant selection window apply to topical antibiotics?

 

Click here to read the article

Sponsor
This educational supplement is sponsored by Foamix Pharmaceuticals Inc.
Sponsor Teaser Title Override
Sponsored Best Practices
Publications
Topics
Sections
Sponsor
This educational supplement is sponsored by Foamix Pharmaceuticals Inc.
Sponsor
This educational supplement is sponsored by Foamix Pharmaceuticals Inc.

James Q. Del Rosso, DO, answers important questions on antibiotic resistance and what it means for the practicing dermatologist.

Questions include:

  • What is the potential magnitude of concern regarding antibiotic resistance? Is it clinically relevant to dermatologists in their day-to-day practice?

  • What can dermatologists do to slow the development of antibiotic resistance?

  • What is the mutant selection window?

  • How does the mutant selection window apply to topical antibiotics?

 

Click here to read the article

James Q. Del Rosso, DO, answers important questions on antibiotic resistance and what it means for the practicing dermatologist.

Questions include:

  • What is the potential magnitude of concern regarding antibiotic resistance? Is it clinically relevant to dermatologists in their day-to-day practice?

  • What can dermatologists do to slow the development of antibiotic resistance?

  • What is the mutant selection window?

  • How does the mutant selection window apply to topical antibiotics?

 

Click here to read the article

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 09/19/2019 - 14:00
Un-Gate On Date
Thu, 09/19/2019 - 14:00
Use ProPublica
CFC Schedule Remove Status
Thu, 09/19/2019 - 14:00
Hide sidebar & use full width
render the right sidebar.
Sponsor Teaser Title Override
Sponsored Best Practices

Pediatric Vaccines & Infectious Diseases: September 2019

Article Type
Changed
Mon, 09/16/2019 - 15:22

Click here to read the supplement.

The 2019 Pediatric Vaccines & Infectious Diseases supplement features a selection of articles published in Pediatric News , with commentary by Kristina A. Bryant, MD.

Dr. Bryant is a pediatrician specializing in infectious diseases at the University of Louisville (Ky.) and Norton Children’s Hospital, also in Louisville. She reported serving as a clinical investigator on trials of pneumococcal conjugate vaccines and the MenB vaccine funded by Pfizer.

Highlights include:

  • Combo vaccines for infants provides lasting hepatitis B immunity for teens
  • Most doctors don’t discuss MenB vaccines
  • Combo respiratory test misses pertussis. Use PCR

Click here to read the supplement.

Publications
Sections

Click here to read the supplement.

The 2019 Pediatric Vaccines & Infectious Diseases supplement features a selection of articles published in Pediatric News , with commentary by Kristina A. Bryant, MD.

Dr. Bryant is a pediatrician specializing in infectious diseases at the University of Louisville (Ky.) and Norton Children’s Hospital, also in Louisville. She reported serving as a clinical investigator on trials of pneumococcal conjugate vaccines and the MenB vaccine funded by Pfizer.

Highlights include:

  • Combo vaccines for infants provides lasting hepatitis B immunity for teens
  • Most doctors don’t discuss MenB vaccines
  • Combo respiratory test misses pertussis. Use PCR

Click here to read the supplement.

Click here to read the supplement.

The 2019 Pediatric Vaccines & Infectious Diseases supplement features a selection of articles published in Pediatric News , with commentary by Kristina A. Bryant, MD.

Dr. Bryant is a pediatrician specializing in infectious diseases at the University of Louisville (Ky.) and Norton Children’s Hospital, also in Louisville. She reported serving as a clinical investigator on trials of pneumococcal conjugate vaccines and the MenB vaccine funded by Pfizer.

Highlights include:

  • Combo vaccines for infants provides lasting hepatitis B immunity for teens
  • Most doctors don’t discuss MenB vaccines
  • Combo respiratory test misses pertussis. Use PCR

Click here to read the supplement.

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 10/10/2018 - 14:30
Un-Gate On Date
Wed, 10/10/2018 - 14:30
Use ProPublica
CFC Schedule Remove Status
Wed, 10/10/2018 - 14:30
Hide sidebar & use full width
render the right sidebar.

Abstracts Presented at the 2019 AVAHO Annual Meeting (Digital Edition)

Article Type
Changed
Wed, 09/09/2020 - 14:14
Display Headline
Abstracts Presented at the 2019 AVAHO Annual Meeting
September 20-22, 2019 ► Minneapolis, MI
Publications
Topics
Sections
September 20-22, 2019 ► Minneapolis, MI
September 20-22, 2019 ► Minneapolis, MI
Publications
Publications
Topics
Article Type
Display Headline
Abstracts Presented at the 2019 AVAHO Annual Meeting
Display Headline
Abstracts Presented at the 2019 AVAHO Annual Meeting
Sections
Citation Override
Fed Pract. 2019 August;36(suppl)
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 09/12/2018 - 10:15
Un-Gate On Date
Wed, 09/12/2018 - 10:15
Use ProPublica
CFC Schedule Remove Status
Wed, 09/12/2018 - 10:15
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article